Incyte Corp at Evercore ISI Healthcare Conference Transcript
Thanks for joining, everyone. We have Bill Meury and Pablo Cagnoni from Incyte. I'm super happy to have both of you guys up here.
Questions & Answers
Really big year to the company, big year ahead next year, too. Maybe you can just open it off with where things stand today, and then we'll get into some more detail in Q&A.
Yeah. Thanks. It's great to be here. Our focus right now is, I think, pretty simple, which is to transition the company from Jakafi to a hem/onc I&I company. And essentially, what we're trying to do is build the glide path to high growth and durable revenue earnings and cash flow post 2029, post Jakafi. There's a lot of substrate in the company. We have the R&D and commercial capabilities to execute.
We kind of break the business down into three parts. There's a core business,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
